Advertisement
Screener

CYTOSORBENTS CORPORATION (CTSO) Graph

CTSO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $9.63M; Revenue including tax (m); Cost of revenue $2.58M; Research and development $1.45M.
  • 2026-03-31: Revenue (m); Revenue including tax $8.86M; Cost of revenue $2.73M; Research and development $1.02M.
  • 2025-12-31: Revenue (m); Revenue including tax $9.23M*; Cost of revenue $2.43M*; Research and development (m).
  • 2025-09-30: Revenue (m); Revenue including tax $9.48M; Cost of revenue $2.82M; Research and development (m).

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CTSO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.All Other Countries$6.89MDE$2.54MUS$200.00KRevenue$9.63MCost of revenue$2.58MGross profit$7.05MOperating expenses$9.69MOperating income-$2.64MResearch & development$1.45MSelling, general& administrative$7.96MIncome tax$0.00Net income-$4.42M

Contract With Customer Sales Channel

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CTSO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Sales ChannelDirectly To Consumer$5.01MSales ChannelThrough Intermediary$4.62MRevenue$9.63MCost of revenue$2.58MGross profit$7.05MOperating expenses$9.69MOperating income-$2.64MResearch & development$1.45MSelling, general& administrative$7.96MIncome tax$0.00Net income-$4.42M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CTSO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Single ReportableSegment$9.63MRevenue$9.63MCost of revenue$2.58MGross profit$7.05MOperating expenses$9.69MOperating income-$2.64MResearch & development$1.45MSelling, general& administrative$7.96MIncome tax$0.00Net income-$4.42M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$9.63M(m)$2.58M$1.45M$7.96M$9.69M$0.00-$4.42M
2026-03-31(m)$8.86M$2.73M$1.02M$8.15M$9.17M$0.00-$5.13M
2025-12-31(m)$9.23M*$2.43M*(m)$9.44M*$11.19M*$0.00*(m)
2025-09-30(m)$9.48M$2.82M(m)$8.61M$9.53M-$401.00K-$3.17M
2025-06-30$9.62M$9.62M$2.80M$1.26M$9.17M$10.43M$0.00$1.95M
2025-03-31(m)$8.73M$2.52M$1.66M$8.43M$10.10M$0.00-$1.48M
2024-09-30(m)$8.61M$3.36M$1.85M$8.26M$10.09M$0.00-$2.77M
2024-06-30(m)$8.84M$2.34M$1.52M$8.55M$10.07M(m)-$4.29M
2024-03-31(m)$8.99M$2.12M$2.25M$9.28M$11.53M$0.00-$6.09M
2023-12-31(m)$8.67M(m)(m)(m)(m)(m)(m)
2023-09-30(m)$8.81M$3.20M$3.75M$8.10M$12.96M$0.00-$9.19M
2023-06-30(m)$9.42M$3.40M$3.67M$7.72M$12.58M(m)-$6.15M
2023-03-31(m)$9.45M$3.99M$4.21M$8.46M$13.35M(m)-$7.33M
2022-12-31(m)$9.39M(m)(m)(m)(m)(m)(m)
2022-09-30(m)$8.11M$4.49M$3.29M$8.74M$12.63M$0.00-$12.20M
2022-06-30(m)$8.50M$3.55M$4.18M$8.44M$13.30M$0.00-$10.88M
2022-03-31(m)$8.69M$2.28M$4.24M$9.16M$14.20M$0.00-$8.97M
2021-12-31(m)$10.78M(m)(m)(m)(m)(m)(m)
2021-09-30(m)$9.76M$2.46M$4.26M$7.78M$12.70M$0.00-$6.41M
2021-06-30(m)$12.02M$2.71M$3.70M$9.82M$14.24M$0.00-$4.68M
2021-03-31(m)$10.60M$2.75M$2.28M$7.71M$10.70M$0.00-$4.17M
2020-12-31(m)$11.96M(m)(m)(m)(m)(m)(m)
2020-09-30(m)$10.55M$2.89M$1.75M$7.28M$9.62M$0.00-$839.73K
2020-06-30(m)$9.79M$3.25M$2.41M$6.59M$9.84M$0.00-$2.87M
2020-03-31(m)$8.71M$2.38M$1.97M$6.32M$8.80M$0.00-$3.45M
2019-12-31(m)$7.43M(m)(m)(m)(m)(m)(m)
2019-09-30(m)$6.10M$1.70M$3.19M$6.11M$10.03M$0.00-$6.89M
2019-06-30$6.23M$6.23M$1.83M$2.93M$4.51M$8.03M$0.00-$3.55M
2019-03-31$5.19M$5.19M$1.74M$2.42M$4.76M$7.74M$0.00-$4.88M
2018-12-31$6.08M$6.08M(m)(m)(m)(m)(m)(m)
2018-09-30$5.74M$5.74M$2.05M$1.94M$4.04M$6.40M$0.00-$3.00M
2018-06-30$5.76M$5.76M$1.79M$1.58M$6.12M$8.16M$0.00-$5.82M
2018-03-31$4.92M$4.92M$1.57M$1.73M$4.32M$6.46M$0.00-$2.98M
2017-12-31$4.65M$4.65M(m)(m)(m)(m)(m)(m)
2017-09-30$3.82M$3.82M$1.52M$643.19K$3.57M$4.46M$0.00-$2.05M
2017-06-30$3.57M$3.57M$1.48M$458.03K$3.51M$4.42M$0.00-$1.73M
2017-03-31$3.11M$3.11M(m)$469.55K$2.67M$3.42M$0.00-$1.52M
2016-12-31$3.08M(m)(m)(m)(m)(m)(m)(m)
2016-09-30$2.41M(m)(m)$1.17M$2.14M$3.59M$0.00-$2.19M
2016-06-30$2.22M(m)(m)$1.09M$2.63M$4.04M$0.00-$3.01M
2016-03-31$1.81M(m)(m)$856.12K$1.97M$3.08M$0.00-$1.84M
2015-12-31$1.76M(m)(m)(m)(m)(m)(m)(m)
2015-09-30$1.34M(m)(m)$866.33K$1.70M$2.86M$0.00-$2.85M
2015-06-30$963.94K(m)(m)$801.66K$1.63M$2.73M$0.00$1.43M
2015-03-31$723.07K(m)(m)$951.03K$1.52M$2.68M$0.00-$4.72M
2014-12-31$873.66K(m)(m)(m)(m)(m)(m)(m)
2014-09-30$1.16M(m)(m)$880.29K$1.24M$2.17M(m)-$1.50M
2014-06-30$1.02M(m)(m)$346.99K$1.21M$1.72M(m)-$1.85M
2014-03-31$1.06M(m)(m)$236.77K$1.08M$1.55M(m)-$975.08K
2013-09-30$880.69K(m)(m)$294.20K$687.79K$1.14M(m)-$964.79K
2013-06-30$291.48K(m)(m)$708.16K$600.82K$1.50M(m)-$1.41M
2013-03-31$371.33K(m)(m)$704.14K$613.16K$1.54M(m)-$1.63M
2012-09-30$605.35K(m)(m)$554.27K$359.63K$1.06M$0.00-$651.98K
2012-06-30$83.04K(m)(m)$715.75K$293.18K$1.08M(m)-$1.05M
2012-03-31$50.23K(m)(m)$632.85K$269.47K$1.06M(m)-$1.43M
2011-09-30$0.00(m)(m)$779.59K$352.39K$1.23M$0.00-$1.73M
2011-06-30(m)(m)(m)$854.83K$191.80K$1.11M(m)-$1.34M
2011-03-31(m)(m)(m)$759.16K$270.09K$1.13M(m)-$1.21M
2010-09-30(m)(m)(m)$526.04K(m)$780.66K(m)-$788.44K
2010-06-30(m)(m)(m)$352.89K(m)$674.38K(m)-$676.28K

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$18.50M(m)$5.32M$2.48M$16.07M$18.86M(m)-$9.55M
2025-06-30$18.34M$18.34M$5.32M$2.92M$17.60M$20.52M$0.00$469.00K
2024-06-30(m)$17.83M$4.46M$3.77M$17.84M$21.60M$0.00-$10.38M
2023-06-30(m)$18.87M$7.40M$7.88M$16.19M$25.92M(m)-$13.48M
2022-06-30(m)$17.19M$5.83M$8.43M$17.60M$27.51M$0.00-$19.85M
2021-06-30(m)$22.62M$5.46M$5.98M$17.53M$24.94M$0.00-$8.85M
2020-06-30(m)$18.50M$5.63M$4.37M$12.91M$18.64M$0.00-$6.32M
2019-06-30$11.42M$11.42M$3.57M$5.35M$9.26M$15.77M$0.00-$8.43M
2018-06-30$10.68M$9.68M$3.35M$3.36M$10.39M$14.62M$0.00-$8.80M
2017-06-30$6.68M$5.64M$2.74M$912.30K$6.20M$7.83M$0.00-$3.26M
2016-06-30$4.03M(m)(m)$1.95M$4.60M$7.12M$0.00-$4.84M
2015-06-30$1.69M(m)(m)$1.75M$3.14M$5.41M$0.00-$3.28M
2014-06-30$2.09M(m)(m)$583.77K$2.28M$3.26M(m)-$2.83M
2013-06-30$662.81K(m)(m)$1.41M$1.21M$3.04M(m)-$3.04M
2012-06-30$133.27K(m)(m)$1.39M$562.65K$2.19M(m)-$2.47M
2011-06-30(m)(m)(m)$1.61M$461.89K$2.24M(m)-$2.56M
2010-06-30(m)(m)(m)$1.03M(m)$1.64M(m)-$1.65M

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30(m)$27.83M$8.14M(m)$26.21M$30.05M-$401.00K-$2.70M
2024-09-30(m)$26.44M$7.81M$5.62M$26.10M$31.69M$0.00-$13.15M
2023-09-30(m)$27.68M$10.60M$11.63M$24.36M$38.95M$0.00-$22.67M
2022-09-30(m)$25.30M$10.32M$11.72M$26.34M$40.14M$0.00-$32.05M
2021-09-30(m)$32.38M$7.92M$10.24M$25.31M$37.64M$0.00-$15.25M
2020-09-30(m)$29.05M$8.52M$6.12M$20.19M$28.26M$0.00-$7.16M
2019-09-30(m)$17.52M$5.27M$8.53M$15.37M$25.79M$0.00-$15.32M
2018-09-30$16.42M$16.42M$5.41M$5.30M$14.43M$21.02M$0.00-$11.81M
2017-09-30$10.50M$9.09M$4.25M$1.56M$9.77M$12.29M$0.00-$5.31M
2016-09-30$6.44M(m)(m)$3.12M$6.74M$10.71M$0.00-$6.86M
2015-09-30$3.03M(m)(m)$2.62M$4.84M$8.26M$0.00-$6.13M
2014-09-30$3.25M(m)(m)$1.46M$3.52M$5.43M(m)-$4.33M
2013-09-30$1.54M(m)(m)$1.71M$1.90M$4.18M(m)-$4.01M
2012-09-30$738.61K(m)(m)$1.85M$915.40K$3.16M$0.00-$3.13M
2011-09-30$0.00(m)(m)$2.39M$814.29K$3.47M$0.00-$4.28M
2010-09-30(m)(m)(m)$1.56M(m)$2.42M(m)-$2.43M

Revenue and expense 11 month

Period endNet income
1997-12-31-$5.26M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31(m)$37.06M$10.57M(m)$35.65M$41.24M-$401.00K-$8.20M
2024-12-31(m)$35.59M$10.71M(m)$33.73M$41.34M-$1.69M-$20.72M
2023-12-31(m)$31.08M$9.13M$15.73M$38.31M$53.90M-$813.74K-$29.25M
2022-12-31(m)$34.69M$13.96M$15.12M$34.29M$52.25M-$1.09M-$32.81M
2021-12-31(m)$43.17M$11.05M$16.38M$35.75M$54.86M-$736.00K-$24.56M
2020-12-31(m)$41.00M$11.05M$8.81M$28.46M$40.32M-$1.13M-$7.84M
2019-12-31(m)$24.95M$7.36M$12.09M$22.01M$36.56M-$1.09M-$19.27M
2018-12-31$22.50M$22.50M$7.49M$7.72M$20.87M$30.60M-$619.55K-$17.21M
2017-12-31$15.15M$15.15M$5.52M$3.22M$14.91M$19.47M-$676.74K-$8.46M
2016-12-31$9.53M$8.21M$3.95M$4.07M$11.81M$17.07M-$318.55K-$11.76M
2015-12-31$4.79M(m)(m)$3.87M$6.92M$11.88M-$324.61K-$9.48M
2014-12-31$4.12M(m)(m)$2.43M$5.55M$8.88M-$385.64K-$9.32M
2013-12-31$2.42M(m)(m)$1.74M$2.58M$5.22M-$458.28K-$4.68M
2012-12-31$1.34M(m)(m)$2.53M$1.35M$4.51M-$391.76K-$3.66M
2011-12-31$36.08K(m)(m)$2.89M$1.23M$4.46M(m)-$5.48M
2010-12-31(m)(m)(m)$1.76M(m)$2.82M(m)-$2.91M
2009-12-31(m)(m)(m)(m)(m)(m)(m)-$2.74M
2008-12-31(m)(m)(m)(m)(m)(m)(m)-$3.02M
2007-12-31(m)(m)(m)(m)(m)(m)(m)-$3.35M
2006-12-31(m)(m)(m)(m)(m)(m)(m)-$76.72M
2005-12-31(m)(m)(m)(m)(m)(m)(m)-$3.67M
2004-12-31(m)(m)(m)(m)(m)(m)(m)-$1.10M
2003-12-31(m)(m)(m)(m)(m)(m)(m)-$6.01M
2002-12-31(m)(m)(m)(m)(m)(m)(m)-$11.87M
2001-12-31(m)(m)(m)(m)(m)(m)(m)-$15.39M
2000-12-31(m)(m)(m)(m)(m)(m)(m)-$3.07M
1999-12-31(m)(m)(m)(m)(m)(m)(m)-$10.75M
1998-12-31(m)(m)(m)(m)(m)(m)(m)-$1.87M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25